Clinical trial
Impact of Dexmedetomidine Supplemented Analgesia on Incidence of Delirium in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial
NCT03012984 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Dexmedetomidine Supplemented Analgesia on Incidence of Delirium in Elderly Patients After Cancer Surgery: a Multicenter Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 6, 2017
- Completion date
- June 11, 2022
- Enrollment
- 1,500 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, complication, postoperative, delirium, dexmedetomidine, elderly, surgery